Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 19, 2023 09:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces the Presentation of New Preclinical Data on Narazaciclib at the AACR Annual Meeting

NEWTOWN, Pa., April 19, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and...
April 14, 2022 08:30 ET | Source: Celsion Corporation

Celsion and Medidata Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial at 2022 AACR Annual Meeting

Phase Ib dose-escalating OVATION I Study with GEN-1 in advanced ovarian cancer patients was well received at 2022 AACR Annual Meeting LAWRENCEVILLE, N.J., April 14, 2022 (GLOBE NEWSWIRE) --...
April 14, 2022 06:00 ET | Source: InvestmentPitch Media and Rakovina Therapeutics

InvestmentPitch Media Video Discusses Rakovina Therapeutics and its Presentation of Preclinical Data Supporting Potential Broad Anticancer Activity of kt-4000 Series at the American Association of Cancer Research Annual General Meeting

VANCOUVER, British Columbia, April 14, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV:RKV), a biopharmaceutical company committed to advancing new cancer therapies based on novel...
April 08, 2022 13:00 ET | Source: ImCheck Therapeutics SAS

ImCheck Provides Updated ICT01 and Pembrolizumab Combination Data from the Phase I/IIa EVICTION Trial at AACR Annual Meeting 2022

ImCheck Provides Updated ICT01 and Pembrolizumab Combination Datafrom the Phase I/IIa EVICTION Trial at AACR Annual Meeting 2022 Continued positive safety data across a range of ICT01 doses...
April 06, 2022 08:30 ET | Source: Stella Diagnostics, Inc

Stella Diagnostics Announces Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting

SALT LAKE CITY, April 06, 2022 (GLOBE NEWSWIRE) -- Stella Diagnostics, Inc. (OTC: SLDX), a molecular diagnostics-based organization optimizing patient management strategies for precancerous and...
March 30, 2022 07:00 ET | Source: NERx Biosciences

NERx Biosciences to Present New Data Highlighting Their Pre-clinical Pipeline of Drugs Targeting the DNA Damage Response at American Association For Cancer Research Annual Meeting in April

INDIANAPOLIS, March 30, 2022 (GLOBE NEWSWIRE) -- NERx Biosciences, an oncology company led by John Turchi and Katherine Pawelczak, will be presenting on two pre-clinical pipeline drugs that may have...
June 04, 2020 07:00 ET | Source: Inivata

Inivata and Collaborators to Present New Data from the RaDaR™ Assay at AACR Virtual Annual Meeting II

Inivata and Collaborators to Present New Data from the RaDaR™ Assay at AACR Virtual Annual Meeting II Data will showcase capabilities of newly launched liquid biopsy assay for the detection of...
April 17, 2018 06:21 ET | Source: Exosome Diagnostics

Exosome Diagnostics Obviates Tissue Biopsies

Waltham, MA, April 17, 2018 (GLOBE NEWSWIRE) -- This groundbreaking observation is presented as Late Breaking Research at the AACR Annual Meeting in Chicago on Tuesday by Dr Sudipto Chakrabortty....